Zheng, S., Lubin, B., Au, R., Murabito, J. M., Benjamin, E. J., & Shwartz, M. (2019). Advantages of Continuous-Valued Risk Scores for Predicting Long-Term Costs: The Framingham Coronary Heart Disease 10-Year Risk Score. Adv Geriatr Med Res.
Style de citation ChicagoZheng, Sarah, Benjamin Lubin, Rhoda Au, Joanne M. Murabito, Emelia J. Benjamin, et Michael Shwartz. "Advantages of Continuous-Valued Risk Scores for Predicting Long-Term Costs: The Framingham Coronary Heart Disease 10-Year Risk Score." Adv Geriatr Med Res 2019.
Style de citation MLAZheng, Sarah, et al. "Advantages of Continuous-Valued Risk Scores for Predicting Long-Term Costs: The Framingham Coronary Heart Disease 10-Year Risk Score." Adv Geriatr Med Res 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.